Literature DB >> 16460897

[ENVOL study on the medical management of varicella and its complications in French ambulatory care].

C Emery1, F Lançon, F Fagnani, M Pechevis, I Durand, D Floret.   

Abstract

OBJECTIVE: The authors had for aim to describe the management of varicella and its complications in French ambulatory care.
METHODS: A descriptive prospective national survey was carried out in France on patients visiting a random sample of French GPs and pediatricians (investigators) having diagnosed varicella. During an inclusion period of 4 months, the investigators enrolled all patients (adults-children) who presented with varicella or varicella related complications, and who had not previously visited the investigator for this episode. Three questionnaires were used to record the data.
RESULTS: One thousand two hundred patients were enrolled by 393 physicians 75% of whom were GPs. Ninety-four percent of patients were children under 13 years of age (group I). The sex ratio (M/F) was 1.1. The mean age was 3.5 years in group I and 23.8 years in patients over 13 years of age (group II). The mean length of the varicella episode was about 10.7 days. Most patients were given a pharmaceutical prescription on inclusion, 1% were also prescribed medical procedures, 0.3% were given local treatment, and 0.09% underwent physical therapy sessions. A proportion of 12.6% of patients visited their physician twice or more for the same episode. Six group I children were hospitalized. Eighty-seven patients presented with at least one complication i.e. 7.8% (95%CI=6.3-9.3) of all episodes, mainly bacterial superinfections.
CONCLUSIONS: The rate of complications associated with varicella infection was higher than usually reported in France but in the same order of magnitude as in other developed countries. Bacterial superinfections were found to be the most frequent complications of varicella.

Entities:  

Mesh:

Year:  2006        PMID: 16460897     DOI: 10.1016/j.medmal.2005.12.001

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  4 in total

1.  Toxin profiling of Staphylococcus aureus strains involved in varicella superinfection.

Authors:  Olivia Raulin; Géraldine Durand; Yves Gillet; Michèle Bes; Gerard Lina; François Vandenesch; Daniel Floret; Jerome Etienne; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2010-03-19       Impact factor: 5.948

2.  The burden of varicella from a parent's perspective and its societal impact in The Netherlands: an Internet survey.

Authors:  Judith H Wolleswinkel-van den Bosch; Anouk M Speets; Hans C Rümke; Pearl D Gumbs; Sander C Fortanier
Journal:  BMC Infect Dis       Date:  2011-11-17       Impact factor: 3.090

3.  Economic burden of varicella in Europe in the absence of universal varicella vaccination.

Authors:  Manjiri Pawaskar; Estelle Méroc; Salome Samant; Elmira Flem; Goran Bencina; Margarita Riera-Montes; Ulrich Heininger
Journal:  BMC Public Health       Date:  2021-12-21       Impact factor: 3.295

Review 4.  Varicella vaccination in Europe - taking the practical approach.

Authors:  Paolo Bonanni; Judith Breuer; Anne Gershon; Michael Gershon; Waleria Hryniewicz; Vana Papaevangelou; Bernard Rentier; Hans Rümke; Catherine Sadzot-Delvaux; Jacques Senterre; Catherine Weil-Olivier; Peter Wutzler
Journal:  BMC Med       Date:  2009-05-28       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.